M. Gruber

发表

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Douglas C. Miller, G. Johnson, J. Babb, 2008, Radiology.

Chapter 183 – Neurologic Complications of Lung Cancer

M. Gruber, 2003 .

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

G Johnson, G. Johnson, S. Cha, 2000, AJNR. American journal of neuroradiology.

Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme.

A. Nirenberg, J. Glass, M. Gruber, 1998, American journal of clinical oncology.

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.

F. Hochberg, J. Glass, M. Gruber, 1994, Journal of neurosurgery.

Involved field radiation therapy after surgical resection of solitary brain metastases--mature results.

J. Golfinos, A. Narayana, E. Connolly, 2013, Neuro-oncology.

CHAPTER 66 – Intracranial Tumors

M. Gruber, D. Rosenbaum, M. MacNeil, 2010 .

Temozolomide in Combination With Irinotecan for Treatment of Recurrent Malignant Glioma

M. Gruber, Ward P. Buster, 2004, American journal of clinical oncology.

Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD)

F. Hochberg, C. Shustik, J. Glass, 1996, Journal of Neuro-Oncology.

High-grade glioma before and after treatment with radiation and Avastin: initial observations.

P. Kelly, J. Golfinos, L. Chiriboga, 2008, Neuro-oncology.

Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission

F. Hochberg, M. Gruber, 1991, Journal of Neuro-Oncology.

Invasion is not an independent prognostic factor in high-grade glioma.

J. Golfinos, A. Narayana, D. Zagzag, 2011, Journal of cancer research and therapeutics.

Pathology with clinical correlations of primary central nervous system non‐Hodgkin's lymphoma. The massachusetts general hospital experience 1958‐1989

N. Harris, Douglas C. Miller, D. Louis, 1994, Cancer.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Radleigh G. Santos, P. Wen, W. Curry, 2019, Clinical Cancer Research.

Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma Multiforme

A. Nirenberg, J. Finlay, H. Hochster, 2000, Journal of Neuro-Oncology.

Change in pattern of relapse after antiangiogenic therapy in high-grade glioma.

J. Golfinos, E. Knopp, A. Narayana, 2012, International journal of radiation oncology, biology, physics.

Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.

P. Kelly, J. Golfinos, E. Knopp, 2008, International journal of radiation oncology, biology, physics.

AT-60A RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL OF DENDRITIC CELL (DC) VACCINE ICT-107 FOLLOWING STANDARD TREATMENT IN NEWLY DIAGNOSED PATIENTS WITH GBM

P. Wen, W. Curry, J. Landolfi, 2014 .

Glioblastoma Multiforme : Multidisciplinary Care and Advances in Therapy

Jordana F Goren, M. Gruber, S. Goldlust, 2008 .

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.

David W. Smith, D. Louis, F. Hochberg, 1992, Journal of neurosurgery.

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

P. Kelly, G. Johnson, J. Golfinos, 2009, Journal of neurosurgery.

A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.

P. Wen, W. Curry, J. Landolfi, 2014 .

Systematic evaluation of primary brain tumors.

F. Hochberg, M. Gruber, F H Hochberg, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion

Douglas C. Miller, G. Johnson, M. Rosenblum, 2007, Journal of magnetic resonance imaging : JMRI.

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.

J. Golfinos, A. Narayana, D. Zagzag, 2012, Journal of neurosurgery.

Echo-Planar MR Cerebral Blood Volume Mapping of Gliomas

Bruce R. Rosen, Hannu J. Aronen, Alan J. Fischman, 1995 .

Susceptibility contrast imaging of cerebral blood volume: Human experience

B. Rosen, A. Fischman, R. Weisskoff, 1991, Magnetic resonance in medicine.

Bevacizumab therapy in recurrent high grade glioma: Impact on local control and survival

G. Johnson, J. Golfinos, E. Knopp, 2008 .

Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.

B. Rosen, A. Fischman, J. Belliveau, 1996, Acta radiologica.

Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.

J. Scott, E. Palmer, A. Fischman, 1996, Clinical nuclear medicine.

Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission

F. Hochberg, M. Gruber, 2004, Journal of Neuro-Oncology.

Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.

A. Narayana, M. Gruber, S. Raza, 2016, Journal of Clinical Oncology.